Purpose: To investigate higher-order aberrations (HOAs) related to increased uncorrected near visual acuity in eyes with aspheric monofocal intraocular lenses.
Methods: All patients underwent phacoemulsification followed by implantation of aspheric monofocal intraocular lenses with a negative spherical aberration (Tecnis one-piece, ZCB00; Abbott Medical Optics, Inc., Milpitas, CA). The distance-corrected near visual acuity (DCNVA), corrected near visual acuity, uncorrected near visual acuity, corrected distance visual acuity, uncorrected distance visual acuity, defocus curve, and ocular and corneal HOAs were examined 1 month after surgery. All near visual acuity measurements were taken with a 4-mm external aperture after pharmacologic dilation. Eyes were divided into two groups according to the DCNVA: eyes with DCNVA of 0.4 logMAR (20/50 Snellen) or better (0.4 logMAR or better group) and eyes with DCNVA worse than 0.4 logMAR (0.4 logMAR or worse group). The HOAs for a 4-mm pupil between the two groups were compared.
Results: A total of 37 eyes of 36 patients were included. The mean ocular spherical aberration was -0.010 ± 0.033 μm in the 0.4 logMAR or better group and -0.012 ± 0.023 μm in the 0.4 logMAR or worse group (P = .28). Among ocular HOAs, only vertical coma Z3(-1) showed a significant difference between the groups, with a mean ocular vertical coma of -0.038 ± 0.043 μm in the 0.4 logMAR or better group and 0.015 ± 0.061 μm in the 0.4 logMAR or worse group (P = .01). In corneal HOAs, no components showed a significant difference between the groups.
Conclusions: In cases of aspheric intraocular lens implantation, ocular vertical coma may be a major HOA associated with better near visual acuity. Although corneal aberrations are major determinants of ocular aberrations after cataract surgery, aberrations from internal optics may still play an important role in visual performance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/1081597X-20140530-01 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High dose aflibercept treatment in naive neovascular age-related macular degeneration.
Int Ophthalmol
January 2025
Beyoglu Eye Training and Research Hospital, University of Health Sciences, Bereketzade Camii Sk. No:2 Beyoğlu, 34421, Istanbul, Turkey.
Background: To evaluate the efficacy and safety of intravitreal injections of 4 mg (high dose) of aflibercept in treatment-naive patients with neovascular AMD(nAMD) with treat and extend(TREX) dosing regimens, and to determine the frequency of injections.
Methods: In this interventional, retrospective study a total of 15 eyes of 14 patients (eight female and 9 male) with nAMD were included. All patients were examined and OCT imaging was performed at the time of initial presentation, on the day of each injection and at subsequent follow-up visits.
Factors associated with the time of glaucoma-related adverse events onset after pediatric cataract surgery and the preferred anti-glaucomatous surgical selection.
Int Ophthalmol
January 2025
Department of Ophthalmology and Visual Science, Eye and ENT Hospital, Shanghai Medical College, Fudan University, 83 Fenyang Road, Shanghai, 200031, China.
Purpose: To describe the clinical characteristics of glaucoma-related adverse events (GRAE) after pediatric cataract surgery. More importantly, to identify the factors associated with the time of GRAE onset and the preferred anti-glaucomatous surgical procedure for this disease.
Methods: Hospitalized medical records of patients who developed GRAE, which include glaucoma and glaucoma suspect, after pediatric cataract surgery (surgical age ≤ 14 years) between 1994 and 2021 were retrospectively reviewed.
Neovascular age-related macular degeneration on three nationwide survey and register data in Finland during 2000-2017.
Acta Ophthalmol
January 2025
Department of Ophthalmology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Purpose: To evaluate time trends in the incidence and prevalence of neovascular age-related macular degeneration (nAMD) and its treatments, associated factors, and effects on vision in Finland during 2000-2017.
Methods: We used three nationwide health examination surveys representing the Finnish population aged 30 years or older. All three surveys were linked to the national care register covering nAMD diagnoses and intravitreal injections between 2000 and 2017.
Societal costs of decreased visual acuity: A Finnish cohort study with 15 years of registry data follow-up.
Acta Ophthalmol
January 2025
Department of Ophthalmology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Purpose: To examine what direct and indirect societal costs are associated with decreased visual acuity (VA).
Methods: Nationally representative sample of 8028 Finnish adults aged 30 years or older with survey data and clinical examination including VA assessment was evaluated. These data were linked with multiple national registers to capture health care services utilization during 1999-2013.
Timing of vitrectomy for treatment of endophthalmitis after intravitreal anti-VEGF injection: a systematic literature review of case reports and series.
Ther Adv Ophthalmol
January 2025
Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Objective: To perform a systematic literature review analyzing visual outcomes of immediate, early, and delayed vitrectomy in the treatment of acute endophthalmitis after intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections.
Methods: We conducted a literature search using the Ovid Medline, Embase.com, and Web of Science databases, and relevant articles were selected from original English papers published from 2005 to 2021.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!